ZENA
ZenaTech, Inc.
ZENA lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
ZENA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Weak |
ZENA's revenue is currently healthy, but its profitability, cash flow and balance sheet are weak.
ZENA PE Valuation
ZENA has no meaningful PE right now: it lost money over the past year.
ZENA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect ZENA's losses to shrink, with revenue growing.
ZENA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.41 | -$1.00 |
| Q1 2026 | -$1.34 | -$1.05 |
| Q4 2025 | -$0.93 | -$0.78 |
| Q3 2025 | -$0.62 | -$0.58 |
| Q2 2025 | -$0.41 | -$0.39 |
| Q1 2025 | -$0.29 | -$0.28 |
| Q4 2024 | -$0.15 | -$0.14 |
| Q3 2024 | -$0.04 | -$0.02 |
ZENA lost $1.41 per share over the past year, and its loss has widened in each of the last nine quarters.
ZENA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.5M | +314% |
| Q1 2026 | $6M | +652% |
| Q4 2025 | $3.6M | +671% |
| Q3 2025 | $3.1M | +1225% |
| Q2 2025 | $1.6M | +504% |
| Q1 2025 | $798.4K | +92% |
| Q4 2024 | $473.4K | -4.4% |
| Q3 2024 | $230.5K | +23% |
ZENA's revenue has grown year over year for six quarters in a row: $7M last quarter, up 314% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -235% | -60 points |
| Q1 2026 | -257% | +6.8 points |
| Q4 2025 | -262% | +97 points |
| Q3 2025 | -101% | +61 points |
| Q2 2025 | -174% | -149 points |
| Q1 2025 | -263% | -269 points |
| Q4 2024 | -359% | -420 points |
| Q3 2024 | -162% | -131 points |
ZENA's operating margin was −235% last quarter, down 60 points from the same quarter a year ago.
ZENA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$18.9M | -$13.7M |
| Q1 2026 | -$14.9M | -$10.9M |
| Q4 2025 | -$14.2M | -$10M |
| Q3 2025 | -$5.9M | -$4.3M |
| Q2 2025 | -$5.2M | -$4.9M |
| Q1 2025 | -$4M | -$3.7M |
| Q4 2024 | -$4.2M | -$2.8M |
| Q3 2024 | -$1.6M | -679% |
ZENA has burned cash in almost every quarter: −$54M over the past year, against −$15M the year before.
ZENA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | 81.3x | High |
| Q2 2024 | 17.6x | High |
| Q1 2024 | 16.8x | High |
| Q4 2023 | 17.2x | High |
| Q3 2023 | 46.4x | High |
| Q2 2023 | 17.0x | High |
| Q1 2023 | 0.0x | Very low |
| Q4 2022 | 8.4x | High |
ZENA's net debt is more than 20 years of its operating earnings (EBITDA), up from more than 20 years a year ago.
ZENA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.3 | Oversold |
| Stochastic | 2.7 | Oversold |
ZENA's weekly RSI is 29 (oversold) and its Stochastic is 3 (oversold).
ZENA PE vs Technology Sector
ZENA has no meaningful PE right now: it lost money over the past year.
ZENA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.01 | 38% below |
| 20 week MA | $1.36 | 54% below |
| 50 week MA | $2.06 | 69% below |
| 100 week MA | $3.23 | 80% below |
ZENA is in a downtrend: it's below all four of its weekly moving averages, and 80% below its 100-week average.
ZENA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $3.91 | $8.48 | +117% |
| 2025 | $8.48 | $3.42 | -60% |
| 2026 YTD | $3.42 | $0.63 | -82% |
ZENA's yearly returns have swung widely, from +117% in 2024 to −60% in 2025. It's down 82% so far in 2026.